Barinthus Biotherapeutics PLC (BRNS) Stock Price, Quote, News & History

BRNSNASDAQ
$0.6521
-0.0486-6.94%
At close: Jun 5, 5:00 PM EST
$0.6013
-0.0508-7.79%
After Hours: Jun 5, 7:37 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-36.44M
Investing Cash Flow (TTM)
476.00K
Financing Cash Flow (TTM)
0
Free Cash Flow (TTM)
-36.48M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-35.97M

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$27.04M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.43
Earnings Yield % (TTM)
-184.08%
Earnings Yield % (FWD)
-164.10%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.63

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$65.86M
Debt to Equity
0.17
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$0.67
Close
$0.65
Volume / Avg.
687.01K / 24.01K
Day Range
$0.65 - $0.70
52 Wk Range
0.51 - 2.92
Market Cap
$24.56M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
-
Short Interest
-
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company is prioritizing the development of its proprietar...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Barinthus Biotherapeutics (BRNS) stock?

A

You can purchase shares of Barinthus Biotherapeutics (NASDAQ:BRNS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Barinthus Biotherapeutics (BRNS) competitors?

A

There are no as such competitors for Barinthus Biotherapeutics.

Q

What is the forecast, or price target, for Barinthus Biotherapeutics (BRNS) stock?

A

Barinthus Biotherapeutics has a consensus price target of $5.50.

Q

What is the current price for Barinthus Biotherapeutics (BRNS)?

A

The stock price for Barinthus Biotherapeutics (NASDAQ: BRNS) is $0.6013 last updated June 5, 2026 at 7:37 PM EDT.

Q

Does Barinthus Biotherapeutics (BRNS) pay a dividend?

A

There are no upcoming dividends for Barinthus Biotherapeutics.

Q

When is Barinthus Biotherapeutics (NASDAQ:BRNS) reporting earnings?

A

Barinthus Biotherapeutics does not have any upcoming earnings scheduled.

Q

Is Barinthus Biotherapeutics (BRNS) going to split?

A

There is no upcoming split for Barinthus Biotherapeutics.

Q

What sector and industry does Barinthus Biotherapeutics (BRNS) operate in?

A

Barinthus Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.